Human chorionic gonadotropin follow-up in patients with molar pregnancy: A time for reevaluation [2] (multiple letters)

Obstetrics and Gynecology

Volumn 102, Issue 3, 2003, Pages 642-643

  Petignat, Patrick ^a   Boulvain, Michel ^a   Vassilakos, Pierre ^a   Feltmate, Colleen M ^b   Bartorsi, Josef ^b   Fulop, Vilmos ^b   Goldstein, Donald P ^b   Berkowitz, Ross S ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; MOLECULAR MARKER; TUMOR MARKER;

CLINICAL FEATURE; DISEASE COURSE; EXPERIENCE; FOLLOW UP; GENETIC ASSOCIATION; HIGH RISK PATIENT; HUMAN; HYDATIDIFORM MOLE; LETTER; MATERNAL CARE; MEDICAL ASSESSMENT; PATIENT; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; TROPHOBLASTIC TUMOR; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETICS; METABOLISM; METHODOLOGY; MONITORING; NOTE; PREGNANCY; SENSITIVITY AND SPECIFICITY; TIME; UTERUS CANCER;

CHORIONIC GONADOTROPIN; FEMALE; FOLLOW-UP STUDIES; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDATIDIFORM MOLE; MONITORING, PHYSIOLOGIC; PREGNANCY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 0142188707     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(03)00687-2     Document Type: Letter

References (6)

1. C.M. Feltmate J. Batorfi V. Fulop D.P. Goldstein J. Doszpod R.S. Berkowitz Human chorionic gonadotropin follow-up in patients with molar pregnancy A time for reevaluation Obstet Gynecol 101 2003 732 736
2. Lawler SD, Fisher RA. Genetic studies in hydatidiform mole with clinical correlations. Placenta 1987;8:77–88
3. N. Wake T. Fujino S. Hoshi N. Shinkai K. Sakai H. Kato The propensity to malignancy of dispermic heterozygous moles Placenta 8 1987 319 326
4. S.D. Lawler R.A. Fisher J. Dent A prospective genetic study of complete and partial hydatidiform moles Am J Obstet Gynecol 164 1991 1270 1277
5. Cho S, Kim SJ. Genetic study of hydatidiform moles by restriction fragment length polymorphisms (RFLPs) analysis. J Korean Med Sci 1993;8:446–52
6. M.J. Seckl R.A. Fisher G. Salerno H. Rees F.J. Paradinas M. Foskett Choriocarcinoma and partial hydatidiform moles Lancet 356 2000 36 39